# Improving Fibrosis Outcomes With Metformin

> **NCT02306070** · PHASE2 · WITHDRAWN · sponsor: **Ottawa Hospital Research Institute**

## Conditions studied

- HIV Infection
- Hepatitis C

## Interventions

- **DRUG:** Metformin
- **DRUG:** No metformin treatment

## Key facts

- **NCT ID:** NCT02306070
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-01
- **Primary completion:** 2017-09-30
- **Final completion:** 2018-04-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** insufficient funding
- **Last updated:** 2018-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02306070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02306070, "Improving Fibrosis Outcomes With Metformin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02306070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*